← Open Payments lookup

MARK GAUTHIER: Open Payments

NPI 1629593355 · WARWICK, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,377 in 67 payments from 10 companies in 2025. Trend: 2023 $1,771 · 2024 $1,552 · 2025 $1,377

Food & beverage: $1,377
CompanyPaymentsAmount
ABBVIE INC.23$459
Vanda Pharmaceuticals Inc.15$320
Axsome Therapeutics, Inc.6$173
Alkermes, Inc.5$101
E.R. Squibb & Sons, L.L.C.5$89
Otsuka America Pharmaceutical, Inc.4$68
Supernus Pharmaceuticals, Inc.3$53
Neurocrine BioSciences, Inc.2$50
Lundbeck LLC3$48
Teva Pharmaceuticals USA, Inc.1$18

Products named: VRAYLAR, FANAPT, Auvelity, REXULTI, COBENFY, ARISTADA, Qelbree, INGREZZA.

Industry payments across RI — which companies pay providers there.